8 results on '"Aurrekoetxea, Igor"'
Search Results
2. Targeting E2F Sensitizes Prostate Cancer Cells to Drug-Induced Replication Stress by Promoting Unscheduled CDK1 Activity.
- Author
-
Hamidi, Mohaddase, Eriz, Ainhoa, Mitxelena, Jone, Fernandez-Ares, Larraitz, Aurrekoetxea, Igor, Aspichueta, Patricia, Iglesias-Ara, Ainhoa, and Zubiaga, Ana M.
- Subjects
- *
PROTEIN metabolism , *REVERSE transcriptase polymerase chain reaction , *DNA , *ANIMAL experimentation , *CELL cycle proteins , *GENE expression , *CELLULAR signal transduction , *BIOINFORMATICS , *TRANSCRIPTION factors , *PHYSIOLOGICAL research , *CELL lines , *PROSTATE tumors , *ANIMALS , *MICE - Abstract
Simple Summary: E2F1 and E2F2 are highly expressed in many cancer types, but their contribution to malignancy is not well understood. Here we aimed to define the impact of E2F1/E2F2 deregulation in prostate cancer. We show that inhibition of E2F sensitizes prostate cancer cells to drug-induced replication stress and cell death. We found that E2F target genes involved in nucleotide biosynthesis contribute to maintaining genome stability in prostate cancer cells, but their enzymatic activity is insufficient to prevent replication stress after E2F1/E2F2 depletion. Instead, E2F1/E2F2 hinder premature CDK1 activation during S phase, which is key to ensure genome stability and viability of prostate cancer cells. From a therapeutic perspective, inhibiting E2F activity provokes catastrophic levels of replication stress and blunts xenograft growth in combination with drugs targeting nucleotide biosynthesis or DNA repair. Our results highlight the suitability of targeting E2F for the treatment of prostate cancer. E2F1/E2F2 expression correlates with malignancy in prostate cancer (PCa), but its functional significance remains unresolved. To define the mechanisms governed by E2F in PCa, we analyzed the contribution of E2F target genes to the control of genome integrity, and the impact of modulating E2F activity on PCa progression. We show that silencing or inhibiting E2F1/E2F2 induces DNA damage during S phase and potentiates 5-FU-induced replication stress and cellular toxicity. Inhibition of E2F downregulates the expression of E2F targets involved in nucleotide biosynthesis (TK1, DCK, TYMS), whose expression is upregulated by 5-FU. However, their enzymatic products failed to rescue DNA damage of E2F1/E2F2 knockdown cells, suggesting additional mechanisms for E2F function. Interestingly, targeting E2F1/E2F2 in PCa cells reduced WEE1 expression and resulted in premature CDK1 activation during S phase. Inhibition of CDK1/CDK2 prevented DNA damage induced by E2F loss, suggesting that E2F1/E2F2 safeguard genome integrity by restraining CDK1/CDK2 activity. Importantly, combined inhibition of E2F and ATR boosted replication stress and dramatically reduced tumorigenic capacity of PCa cells in xenografts. Collectively, inhibition of E2F in combination with drugs targeting nucleotide biosynthesis or DNA repair is a promising strategy to provoke catastrophic levels of replication stress that could be applied to PCa treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. THU-210 Dysfunctional activation of the DNA damage response is associated with MASLD progression through an E2F2-dependent mechanism.
- Author
-
Santos, Beatriz Gómez, Fernández-Puertas, Idoia, Gomez-Jauregui, Paul, Sainz-Ramírez, Natalia, Alfaro-Jiménez, Kendall, Castillero, Estibaliz, Nieva-Zuluaga, Ane, Apodaka-Biguri, Maider, Aurrekoetxea, Igor, Delgado, Igotz, Lopategi, Aritz, Iglesias, Ainhoa, González, Lorena Mosteiro, Olartekoetxea, Gaizka Errazti, Gaztambide, Sonia, González, Luis A. Castaño, Bujanda, Luis, Banales, Jesus Maria, Buque, Xabier, and Zubiaga, Ana
- Published
- 2024
- Full Text
- View/download PDF
4. FRI-472-YI Mitochondrial metabolism is disrupted by ciprofloxacin preventing cholangiocarcinoma cell proliferation.
- Author
-
de Gauna, Mikel Ruiz, Alfaro-Jiménez, Kendall, Nieva-Zuluaga, Ane, Apodaka-Biguri, Maider, Markaide, Enara, Izquierdo-Sánchez, Laura, Rae, Colin, González-Romero, Francisco, Gomez-Jauregui, Paul, Sainz-Ramírez, Natalia, Santos, Beatriz Gómez, Buque, Xabier, Aurrekoetxea, Igor, Delgado, Igotz, Fernández-Puertas, Idoia, Iglesias, Ainhoa, Rourke, Colm O., Rodrigues, Pedro Miguel, Andersen, Jesper, and Calvisi, Diego
- Published
- 2024
- Full Text
- View/download PDF
5. Liver osteopontin is required to prevent the progression of age‐related nonalcoholic fatty liver disease.
- Author
-
Gómez‐Santos, Beatriz, Saenz de Urturi, Diego, Nuñez‐García, Maitane, Gonzalez‐Romero, Francisco, Buque, Xabier, Aurrekoetxea, Igor, Gutiérrez de Juan, Virginia, Gonzalez‐Rellan, Maria J., García‐Monzón, Carmelo, González‐Rodríguez, Águeda, Mosteiro, Lorena, Errazti, Gaizka, Mifsut, Patricia, Gaztambide, Sonia, Castaño, Luis, Martin, Cesar, Nogueiras, Rubén, Martinez‐Chantar, María L., Syn, Wing‐Kin, and Aspichueta, Patricia
- Subjects
- *
FATTY liver , *OSTEOPONTIN , *ANIMAL models for aging , *LIVER , *LIPID metabolism , *P53 antioncogene , *LIVER cells - Abstract
Osteopontin (OPN), a senescence‐associated secretory phenotype factor, is increased in patients with nonalcoholic fatty liver disease (NAFLD). Cellular senescence has been associated with age‐dependent hepatosteatosis. Thus, we investigated the role of OPN in the age‐related hepatosteatosis. For this, human serum samples, animal models of aging, and cell lines in which senescence was induced were used. Metabolic fluxes, lipid, and protein concentration were determined. Among individuals with a normal liver, we observed a positive correlation between serum OPN levels and increasing age. This correlation with age, however, was absent in patients with NAFLD. In wild‐type (WT) mice, serum and liver OPN were increased at 10 months old (m) along with liver p53 levels and remained elevated at 20m. Markers of liver senescence increased in association with synthesis and concentration of triglycerides (TG) in 10m OPN‐deficient (KO) hepatocytes when compared to WT hepatocytes. These changes in senescence and lipid metabolism in 10m OPN‐KO mice liver were associated with the decrease of 78 kDa glucose‐regulated protein (GRP78), induction of ER stress, and the increase in fatty acid synthase and CD36 levels. OPN deficiency in senescent cells also diminished GRP78, the accumulation of intracellular TG, and the increase in CD36 levels. In 20m mice, OPN loss led to increased liver fibrosis. Finally, we showed that OPN expression in vitro and in vivo was regulated by p53. In conclusion, OPN deficiency leads to earlier cellular senescence, ER stress, and TG accumulation during aging. The p53‐OPN axis is required to inhibit the onset of age‐related hepatosteatosis. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
6. PS-008-E2F2 mediated repression of fatty acid B-oxidation is mitigated through CREB1 in progressive non-alcoholic fatty liver disease.
- Author
-
Gonzalez-Romero, Francisco, Mestre, Daniela, Aurrekoetxea, Igor, Urturi, Diego Sáenz de, Gomez-Santos, Beatriz, Nuñez-García, Maitane, Buqué, Xabier, Delgado, Igotz, Palomo-Irigoyen, Marta, Tamayo-Caro, Miguel, Woodhoo, Ashwin, Varela-Rey, Marta, Martínez-Chantar, María Luz, Iglesias, Ainhoa, Lee, Richard, Bhanot, Sanjay, Zubiaga, Ana, and Aspichueta, Patricia
- Subjects
- *
FATTY liver , *FATTY acids - Published
- 2019
- Full Text
- View/download PDF
7. Schwann cell autophagy, myelinophagy, initiates myelin clearance from injured nerves.
- Author
-
Gomez-Sanchez, Jose A., Carty, Lucy, Iruarrizaga-Lejarreta, Marta, Palomo-Irigoyen, Marta, Varela-Rey, Marta, Griffith, Megan, Hantke, Janina, Macias-Camara, Nuria, Azkargorta, Mikel, Aurrekoetxea, Igor, De Juan, Virginia Gutiérrez, Jefferies, Harold B. J., Aspichueta, Patricia, Elortza, Félix, Aransay, Ana M., Martinez-Chantar, María L., Baas, Frank, Mato, José M., Mirsky, Rhona, and Woodhoo, Ashwin
- Subjects
- *
SCHWANN cells , *AUTOPHAGY , *MYELIN , *PERIPHERAL nervous system , *CYTOLOGICAL research - Abstract
Although Schwann cell myelin breakdown is the universal outcome of a remarkably wide range of conditions that cause disease or injury to peripheral nerves, the cellular and molecular mechanisms that make Schwann cell-mediated myelin digestion possible have not been established. We report that Schwann cells degrade myelin after injury by a novel form of selective autophagy, myelinophagy. Autophagy was up-regulated by myelinating Schwann cells after nerve injury, myelin debris was present in autophagosomes, and pharmacological and genetic inhibition of autophagy impaired myelin clearance. Myelinophagy was positively regulated by the Schwann cell JNK/c-Jun pathway, a central regulator of the Schwann cell reprogramming induced by nerve injury. We also present evidence that myelinophagy is defective in the injured central nervous system. These results reveal an important role for inductive autophagy during Wallerian degeneration, and point to potential mechanistic targets for accelerating myelin clearance and improving demyelinating disease. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
8. S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease.
- Author
-
Martínez-Uña, Maite, Varela-Rey, Marta, Mestre, Daniela, Fernández-Ares, Larraitz, Fresnedo, Olatz, Fernandez-Ramos, David, Juan, Virginia Gutiérrez-de, Martin-Guerrero, Idoia, García-Orad, Africa, Luka, Zigmund, Wagner, Conrad, Lu, Shelly C., García-Monzón, Carmelo, Finnell, Richard H., Aurrekoetxea, Igor, Buqué, Xabier, Martínez-Chantar, M. Luz, Mato, José M., and Aspichueta, Patricia
- Subjects
- *
FATTY liver , *ADENOSYLMETHIONINE , *LOW density lipoproteins , *PROTEIN precursors , *TRIGLYCERIDES , *METHIONINE adenosyltransferase , *PERILIPIN - Abstract
Background & Aims Very-low-density lipoproteins (VLDLs) export lipids from the liver to peripheral tissues and are the precursors of low-density-lipoproteins. Low levels of hepatic S-adenosylmethionine (SAMe) decrease triglyceride (TG) secretion in VLDLs, contributing to hepatosteatosis in methionine adenosyltransferase 1A knockout mice but nothing is known about the effect of SAMe on the circulating VLDL metabolism. We wanted to investigate whether excess SAMe could disrupt VLDL plasma metabolism and unravel the mechanisms involved. Methods Glycine N -methyltransferase ( GNMT ) knockout (KO) mice, GNMT and perilipin-2 ( PLIN2 ) double KO ( GNMT - PLIN2 -KO) and their respective wild type (WT) controls were used. A high fat diet (HFD) or a methionine deficient diet (MDD) was administrated to exacerbate or recover VLDL metabolism, respectively. Finally, 33 patients with non-alcoholic fatty-liver disease (NAFLD); 11 with hypertriglyceridemia and 22 with normal lipidemia were used in this study. Results We found that excess SAMe increases the turnover of hepatic TG stores for secretion in VLDL in GNMT -KO mice, a model of NAFLD with high SAMe levels. The disrupted VLDL assembly resulted in the secretion of enlarged, phosphatidylethanolamine-poor, TG- and apoE-enriched VLDL-particles; special features that lead to increased VLDL clearance and decreased serum TG levels. Re-establishing normal SAMe levels restored VLDL secretion, features and metabolism. In NAFLD patients, serum TG levels were lower when hepatic GNMT-protein expression was decreased. Conclusions Excess hepatic SAMe levels disrupt VLDL assembly and features and increase circulating VLDL clearance, which will cause increased VLDL-lipid supply to tissues and might contribute to the extrahepatic complications of NAFLD. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.